Scott C. Kachlany
Founder at Actinobac Biomed, Inc.
Scott C. Kachlany active positions
| Companies | Position | Start | End |
|---|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Founder | 16/07/2009 | - |
| Chief Tech/Sci/R&D Officer | 31/12/2008 | - | |
| Director/Board Member | 31/12/2008 | - | |
| Corporate Officer/Principal | - | - | |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Director/Board Member | - | - |
Career history of Scott C. Kachlany
Former positions of Scott C. Kachlany
| Companies | Position | Start | End |
|---|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 31/12/2002 | - |
Training of Scott C. Kachlany
| Cornell University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
- Stock Market
- Insiders
- Scott C. Kachlany
- Experience
